- IL-35: A potential therapeutic target for controlling hepatitis B virus infectionXiang Xiao Gang; Xie QingJournal of Digestive Diseases, 2015, 16(1): 1-6.
- EXPLORING THE ROLE OF A CD40 FUNCTIONAL VARIANT IN HBV CLEARANCE REVEALS A NOVEL PREDICTOR OF PEGIFNα TREATMENT RESPONSEChen, Jiaxuan; Chen, Haitao; Mai, Haoming; Lou, Shuang; Luo, Mengqi; Xie, Haisheng; Zhou, Bin; Hou, JinLin; Jiang, Deke
- TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg-positive chronic hepatitis B PatientsLuo, Mengqi; Hou, Jia; Mai, Haoming; Chen, Jiaxuan; Chen, Haitao; Zhou, Bin; Hou, Jinlin*; Jiang, De-Ke*Alimentary Pharmacology and Therapeutics, 2022, 56(5): 878-889.被引 9
会议论文
TRIM26 INHIBITS HEPATITIS B VIRUS REPLICATION BY PROMOTING HBx DEGRADATION AND TRIM26 GENETIC POLYMORPHISM PREDICTS PEGIFNA TREATMENT RESPONSE OF HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS
16阅读
